Drug Discovery - Publications - Faculty & Research - Harvard Business School

Filter Results: (110)

Filter Results: (110)

Show Results For

← Page 3 of 110 Results →

September 2024
Case

Google Quantum AI

By: David B. Yoffie, Michael A. Cusumano and Matt Higgins

Quantum computing may be the most important nascent computing technology of the 21st century. It has the potential to impact industries ranging from drug discovery to cybersecurity. Google's Quantum AI is one of the leaders in quantum research. This case explores the... View Details

Keywords: Business Model; Price; Technological Innovation; Resource Allocation; Business Strategy; Information Technology Industry

March 2008
Case

Novartis AG: Science-Based Business

By: H. Kent Bowen and Courtney Purrington

Novartis is a science-based drug company, which has important implications for its business strategy. It is one of the largest pharmaceutical companies in the world with over $38B in sales in 2007. Pharmaceuticals account for slightly over $24B of that total. In 2007,... View Details

Keywords: Innovation and Invention; Resource Allocation; Product Development; Partners and Partnerships; Research and Development; Science-Based Business; Pharmaceutical Industry

July 2024
Case

Gates Ventures: Making Alzheimer's a Forgotten Past

By: Satish Tadikonda, William Marks, Shardule Shah and Calvin Marambo

After a personal journey and interest in Alzheimer's Disease (AD) by Bill Gates, Gates Ventures set out to find the best way to accelerate innovation in the field of AD. In partnership with the Alzheimer's Drug Discovery Foundation, Gates Ventures created the... View Details

Keywords: Philanthropy and Charitable Giving; Entrepreneurial Finance; Health Disorders; Mission and Purpose

September 2020
Case

Minerva 2010: Turbulent Times

By: John R. Wells and Benjamin Weinstock

In 2010, amid a flurry of new discoveries, Cynthia Bamdad, founder and CEO of Minerva Biotechnologies Corporation (Minerva), raised $6.6 million to test her new cancer drugs in mice. It had been more than 6 years since she had announced that she and her small team at... View Details

Keywords: Biotechnology; Research; Product Development; Commercialization; Strategy

17 Jun 2019
Blog Post

Why I Would Have Applied to the MS/MBA Biotechnology: Life Sciences Program

and drug development. These qualities straddle the science and business fields – for example, to instill a science-focused culture within an organization, or to craft a drug development strategy that... View Details

04 Sep 2018
First Look

New Research and Ideas, September 4, 2018

moral imperatives, we study the factors that influence when individuals find solutions that fall outside of the salient options presented. In particular, we study moral insight, or the discovery of solutions, other than selecting one of... View Details

Keywords: Dina Gerdeman

25 Mar 2016
HBS Seminar

Curtis Keith, Harvard University, Blavatnik Biomedical Accelerator

Research Summary

Overview

By: Joshua Lev Krieger

In examining the competitive dynamics of R&D strategy, Josh has become particularly interested in how the introduction of new knowledge generated by rivals impacts the direction of R&D efforts. Understanding how new information alters project portfolio decisions is... View Details

Web

MS/MBA Biotechnology: Life Sciences | MBA

new drug discoveries and therapeutics. The program is completed over two academic years, utilizing January terms and time in August at the start of the program. The curriculum emphasizes developing effective... View Details

Web

Overview | MBA

relevant timeframes, opportunity-costs, rewards, and organizational behavior. Assess the potential therapeutic value of discoveries emanating from lab-discovery in the life sciences and understand ways to accelerate these View Details

Web

Capstone | MBA

that will advance new drug discoveries and therapeutics with those equally passionate about changing the business of healthcare for the better. 2. The practicalities of business decisions meet the... View Details

Web

Faculty & Advisors | MBA

Sclerosis, Ischemic Stroke, and Neuro-Oncology. A tech-bio company co-founded with Mayo Clinic, Ibis Therapeutics’ AI-driven Dynamic Fingerprint Platform engine enables the discovery of novel compounds and selection of patient cohorts... View Details

Web

Blavatnik Fellowship in Life Science Entrepreneurship - Health Care

Andrew will be growing Modulate Bio’s drug discovery platform, focused on developing novel small molecule GABAa positive allosteric modulators (PAMs) with improved efficacy and safety. Andrew was previously... View Details

Web

Degrees, Certifications & Alumni Status | About

grow transformative organizations that will advance new drug discoveries or therapeutics. The MS/MBA: Engineering Sciences Program Grants : Master in Business Administration from Harvard Business School... View Details

Web

Fostering Innovation in Life Sciences - Health Care

the vibrant entrepreneurial community at Harvard. GETTING LIFE-SAVING DRUGS TO MARKET is a research focus for Professor Amitabh Chandra . He examines the unique effects that economics and market factors have on the development of... View Details

Web

Profiles - MBA

optimization in deep neural network training, and reinforcement learning in drug design and delivery for my senior thesis. Formative experience at the intersection of technology and business At Kensho, an AI/ML fintech company, I learned... View Details

26 Aug 2024
Blog Post

HBS Lingo 101

Program. Graduates earn two degrees in two years and are prepared to grow transformative organizations that will advance new drug discoveries or therapeutics. HIVES: Classrooms in Batten Hall designed with... View Details

01 Jun 2024
News

Quantum Leap

day quantum computing becomes a reality is the day conventional digital security ends.) They should even be able to do things that digital computers cannot do at all, like realistically modeling molecules for more efficient drug View Details

Keywords: Alexander Gelfand; photographed by Chris Sorensen; quantum computing; innovation; leadership; Computer and Electronic Product Manufacturing; Manufacturing

05 Jul 2006
Research & Ideas

The Accidental Innovator

Business School, while Devin is professor emeritus from Swarthmore College. Sarah Jane Gilbert: Can you explain what accidental innovation is? What led to your interest in researching this concept? Robert Austin: Historical accounts of many important View Details

Keywords: by Sarah Jane Gilbert

22 Aug 2005
Research & Ideas

The Hard Work of Failure Analysis

the hospital quickly followed their example, finding the idea compelling and practical. In the pharmaceutical industry, about 90 percent of newly developed drugs fail in the experimental stage, and thus drug... View Details

Keywords: by Amy Edmondson & Mark D. Cannon

←
3
4
5
6
→